In the extensive experiments in vitro degradation ability of hydrothermically and thermically treated feeds have been studied. The feeds used were soybean meal, horse bean, alfalfa meal, field pea. The feeds have been treated at 90, 110 and 130 degrees C for 30, 60 and 90 min. The treated feeds have been tested both for microbial degradation ability due to rumen microflora and enzymatic degradation ability via pepsin and trypsin. The fact has been regarded as an important finding that the degradation ability of nitrogenous compounds had been restricted effectively by hydrothermic treatment that was manifested by low ammonia-N levels in fermentation medium (11.3; 8.8; 15.9 and 1.1% out of nitrogen contents in the different feeds). On the other hand improved protein enzymatic digestibility have been recorded in treated feeds as compared with native ones.

Download full-text PDF

Source
http://dx.doi.org/10.1080/17450398709425384DOI Listing

Publication Analysis

Top Keywords

treated feeds
20
degradation ability
16
feeds
8
fermentation medium
8
treated
6
study changes
4
changes properties
4
properties thermically
4
thermically hydrothermically
4
hydrothermically treated
4

Similar Publications

This study aimed to develop the 'Fear of Feeding My Child- A Parental Report (FF-PR)', which measures the parental fear of feeding their children, and to determine its reliability and validity. The study consists of the developmental phase and reported the content validity, internal consistency, test-retest reliability, construct, criterion, and discriminant validity. The study included two groups; 'Group I (N = 90)' who had a neurological disorder and their parents, and 'Group II (N = 60)' who were typically developing children without any feeding and swallowing problems and their parents.

View Article and Find Full Text PDF

[Growth and development patterns of Noonan syndrome and advances in the treatment of short stature].

Zhongguo Dang Dai Er Ke Za Zhi

January 2025

Department of Endocrinology, Metabolism and Genetics, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

Patients with Noonan syndrome (NS) are born with normal or slightly lower body length and weight compared to the normal ranges. However, their height gradually falls behind that of the general population, leading to growth retardation and delayed puberty. In China, the incidence of short stature in patients with NS is approximately 65%.

View Article and Find Full Text PDF

Antioxidant and anti-aging activities of Acanthopanax senticosus polysaccharide CQ-1 in nematode Caenorhabditis elegans.

Int J Biol Macromol

January 2025

Shandong Provincial Third Hospital, Shandong University, Jinan 250031, China; Department of Microbiology and Synthetic Biology, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China. Electronic address:

Acanthopanax senticosus is a typical food medicine homology in China. The antioxidant and anti-aging activities of A. senticosus polysaccharides, especially the purified polysaccharide, have not been thoroughly investigated.

View Article and Find Full Text PDF

A two-month-old developmentally normal full-term female presented with severe feeding intolerance, progressive weight loss, and persistent fussiness, leading to multiple emergency department visits and eventual hospitalization. Initial evaluations, including laboratory tests and imaging, were unremarkable, prompting a series of diagnostic and therapeutic interventions. A multidisciplinary approach, including empiric gastroesophageal reflux disease (GERD) therapy, was started.

View Article and Find Full Text PDF

CLN2 and CLN3 diseases, the most common types of Batten disease (also known as neuronal ceroid lipofuscinosis), are childhood dementias associated with progressive loss of speech, language and feeding skills. Here we delineate speech, language, non-verbal communication and feeding phenotypes in 33 individuals (19 females) with a median age of 9.5 years (range 3-28 years); 16 had CLN2 and 17 CLN3 disease; 8/15 (53%) participants with CLN2 and 8/17 (47%) participants with CLN3 disease had speech and language impairments prior to genetic diagnosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!